gyrA mutations in quinolone-resistant pathogenic isolates of Staphylococcus spp. have been detected by the direct Hinfl digestion of polymerase chain reaction products. Homology among gyrA genes allowed rapid examination of both coagulase-positive and -negative isolates. DNA sequence analysis revealed that ciprofloxacin resistance in Staphylococcus epidermidis is associated with a novel Ser-84-*Phe mutation in the DNA gyrase A protein, analogous to Ser-84->Leu changes observed in Staphylococcus aureus.
Members of the genus Staphylococcus are major human pathogens (4) . Coagulase-positive Staphylococcus aureus strains cause a variety of nosocomial infections, including postoperative septicemia. Recent experience has also emphasized the importance of coagulase-negative species. Staphylococcus epidermidis has risen to prominence through its frequent association with hemodialysis shunts, indwelling catheters, artificial heart valves, and other prosthetic implants that are used increasingly in modern medicine (17) . Similarly, Staphylococcus saprophyticus is now recognized as a common cause of female urinary tract infections (12) . Antibacterial fluoroquinolones such as ciprofloxacin have been effective in treating staphylococcal infections, especially those caused by methicillin-resistant strains (7, 9, 18) . Unfortunately, widespread use of these agents has led to the marked emergence of resistance, notably among S. aureus and S. epidermidis isolates (3, 11, 21, 22) .
The mechanisms of quinolone resistance in Staphylococcus spp. are poorly understood. Most studies have focused on S. aureus. One resistance pathway appears to involve alterations in DNA gyrase, an A2B2 complex encoded by the gyrA and gyrB genes that catalyzes ATP-dependent DNA supercoiling and is the intracellular target of the quinolones (5, 6). Thus, the gyrA genes from three ciprofloxacinresistant S. aureus clinical isolates were found to carry Ser-84-*Leu and/or Ser-85--Pro codon changes (23) analogous to the Ser-83--Leu and Ala-84--Pro gyrase A mutations known to confer resistance in Escherichia coli (16, 25) . A second mechanism, conferring norfloxacin resistance, involves norA, a gene that most likely encodes a drug efflux pump (26) . Studies of quinolone resistance in the coagulasenegative staphylococci are less advanced. Norfloxacin resistance genes (possibly similar to norA) have been cloned from S. epidermidis and Staphylococcus haemolyticus (24) . However, the role of gyrase in resistance has yet to be examined. Here we describe a simple, rapid method based on the polymerase chain reaction (PCR) for detecting quinolone resistance mutations in gyrA that is applicable to both coagulase-positive and -negative strains, including S. aureus, S. epidermidis, and S. saprophyticus. We have par-* Corresponding author.
tially characterized the S. epidermidis gyrA gene and identified a novel mutation associated with clinical resistance to ciprofloxacin.
To validate the method, we used three ciprofloxacinresistant S. aureus strains, SA34R, SA31R, and SA42R, generated from the respective susceptible clinical isolates SA34, SA31, and SA42 (23) by incremental stepwise selection on ciprofloxacin plates in vitro (Table 1) . Three S. epidermidis strains obtained from patients at the VA Center, Minneapolis, Minn., were also examined: ciprofloxacinsusceptible isolates SE190 and SE193 and the drug-resistant strain SE197 (Table 1 ). S. saprophyticus NCTC 7292 is a ciprofloxacin-susceptible clinical isolate from urine. Genomic DNA was isolated from each strain (13) and subjected to PCR as previously described, using two 24-mer oligonucleotide primers corresponding to S. aureus gyrA nucleotide positions -15 to +9 (primer 1) and 455 to 478 (primer 2) (Fig.  1A) (23) . A 493-bp gyrA gene fragment was amplified from each isolate (Fig. 1B) . The presence or absence of gyrA mutations at codon 83/84 was then determined by digesting PCR products with Hinfl ( Fig. 1C and D) . Mutations in gyrA that remove this Hinfl site result in a concomitant amino acid substitution at Asp-83/Ser-84 in the gyrase A protein.
The presence of the Hinfl site at nucleotide 247 generates a pair of Hinfl DNA fragments 230 and 189 bp in size, whereas its absence through mutation yields a distinctive 419-bp product (23) (Fig. 1A) . It can be seen that both SA31R and SA42R but not SA34R carry a mutation that eliminates the Hinfl site at nucleotide 247, indicating a mutation in the protein at residue 83 or 84 (Fig. 1C) .
Hinfl digestion of PCR products from ciprofloxacin-susceptible S. epidermidis SE190 and SE193 and S. saprophyticus NCTC 7297 also generated the 189-to 230-bp doublet, showing that gyrA genes from these organisms share substantial homology with that of S. aureus ( Fig. 1C and D) . Interestingly, like SA31R and SA42R, ciprofloxacin-resistant S. epidermidis SE197 gave a 419-bp Hinfl product, revealing the presence of a mutation at residue 84 of the gyrase A protein. DNA sequence analysis was used to characterize the S. aureus and S. epidermidis gyrA genes and their mutations.
PCR products derived from S. aureus DNA were cut with EcoRI and ClaI, cloned into EcoRI-AccI-cut M13mpl8 and ciprofloxacin-resistant clinical S. aureus isolates, SA47 (the matched posttherapy isolate to SA31) and SA146 (23) . Thus, the Ser-84--Leu gyrase A mutation appears to be commonly associated with both clinical and in vitro resistance to ciprofloxacin in S. aureus. Interestingly, the gyrA gene sequence determined for SA34R was found to be wild type, indicating that ciprofloxacin resistance in this strain must arise from other mechanisms, e.g., mutations elsewhere in gyrA or in other genetic loci such as norA or gyrB. It is of course possible that mutations at other loci also contribute to high-level resistance, even in those strains with detectable codon 83/84 gyrA mutations (Table 1) .
S. epidermidis SE190 and SE193 had identical gyrA sequences and showed very close homology with S. aureus gyrA (Fig. 2) . Conserved Hinfl sites at positions 58 and 247 account for the similarity of the Hinfl digestion pattern to that of S. aureus (Fig. 1C) . The gyrA gene fragment from ciprofloxacin-resistant isolate SE197 was identical in sequence to that from SE190 and SE193, except for a C-+T transition at nucleotide 251 that abolishes the natural Hinfl site and generates a novel Ser-84->Phe substitution at the protein level.
These results show that ciprofloxacin resistance in both S. epidermidis and S. aureus is commonly associated with the mutation of the conserved serine 84 residue in the gyrase A protein. Previous studies with E. coli laboratory strain KL16 and E. coli clinical isolates have demonstrated that highlevel quinolone resistance results from analogous Ser-83-*Leu or Trp changes in GyrA protein (2, 16, 25) . In other work, a genetically engineered Ser-83-*Ala gyrA codon change conferred low-level quinolone resistance (8) . In each case, these alterations replace Ser-83 with a hydrophobic residue lacking a hydroxyl side chain. The analogous Ser-84-+Leu or Phe changes found in ciprofloxacin-resistant Staphylococcus spp. fall into the same category. Frequent association of gyrase A mutations at serine 83/84 with quinolone resistance in a range of clinically important organisms merits further analysis of the role of this residue in the interaction of quinolones with gyrase.
Our studies highlight the sequence conservation of gyrA genes among coagulase-positive and -negative staphylococci. We have found only 31 nucleotide differences (89% identity) between the 282-bp S. epidermidis gyrA sequence and that of S. aureus (Fig. 2) . Most of these changes are silent, and the deduced 94-residue gyrase A protein sequence shows only two amino acid differences with the S. aureus protein: Ser-32 for Ala and Ser-63 for Pro (the same gyrase A residues found in Bacillus subtilis, another grampositive organism [14] ). This situation contrasts with the different morphological, biochemical, and physiological features exhibited by staphylococcal species (15, 17) , e.g., coagulase response, cell wall structure (including different penicillin-binding proteins [1, 19] ), and other properties that presumably account for their different pathological niches. Conservation of gyrase A protein sequence may reflect the critical biological importance of the protein and may also account for the broadly similar quinolone susceptibilities among the staphylococci (Table 1) . By exploiting this homology, PCR techniques should allow alterations in gyrase to be readily detected in a variety of quinolone-resistant staphylococcal isolates.
